Epilepsy Devices Market: Segmented by Product (Conventional devices, Wearable devices); By End-User (Home care settings, Clinics, Hospitals) and Region – Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030
178+ Pages Research Report Epilepsy Devices market to surpass USD 1115.3 million by 2030 from USD 587.4 million in 2020 at a CAGR of 6.62% in the coming years, i.e., 2021-30.
Product Overview
Epilepsy is a chronic neurological condition that produces repeated unprovoked seizures, which are characterized by undetected episodes of uncontrollable movement involving either a portion or full body. The underlying cause of epilepsy, however, remains unclear. Epilepsy can be caused by strokes, trauma, brain tumors, infections, or birth defects in certain people. Because the condition is more common in children than in adults, general practitioners are more likely to see patients with epilepsy in their everyday practice. Depending on the symptoms of epilepsy, blood tests such as complete blood count, magnetic resonance imaging (MRI), computed tomography scanning (CT), and electroencephalograms (EEG) are used to diagnose the condition. The therapeutic gadgets provide novel treatment alternatives for epilepsy.
Market Highlights
Epilepsy Devices market is expected to project a notable CAGR of 6.62% in 2030
The increasing incidence of epilepsy among the geriatric population, rising occurrences of brain injuries due to road accidents, a huge patient pool suffering from neurological diseases, and expanding research funding in epilepsy are all contributing to the global market's growth.
Epilepsy Devices Market: Segments
Conventional devices segment to grow with the highest CAGR during 2020-30
Epilepsy Devices market is segmented by Product into Conventional devices and Wearable devices. Among these Conventional devices is expected to dominate the market during the forecast period. The extensive use of traditional EEG equipment in hospitals and clinics, the rising need for epilepsy monitoring in clinical trials, and the availability of payment for EEG treatments in developed nations all contribute to the segment's rise.
Hospitals & Clinics segment to grow with the highest CAGR during 2020-30
Epilepsy Devices market is segmented by End-User into Hospitals & Clinics, Forensic and Pharmaceutical manufacturing. Among these, the Hospitals & Clinics category had the highest revenue share in 2020. EEG monitoring and emergency medical services are most commonly used in hospitals and clinics. The market is expected to provide profitable opportunities, particularly in developing nations.
Market Dynamics
Drivers
Need for continuous monitoring to rise market growth
Continuous monitoring is required in severely ill epileptic patients to detect non-convulsive episodes (NCS). The cerebral cortical function is assessed by continuous monitoring. NCS is a condition that can affect children with encephalopathy. Adults' NCS outcomes change with time, possibly worsening their health. As a result, the demand for EEG systems rises as the requirement for continuous monitoring grows.
Increasing awareness
The global epilepsy treatment devices market is anticipated to develop due to increased awareness and technical improvements in epilepsy treatment options.
Restraint
Lack of healthcare facilities
The global epilepsy treatment devices market is projected to be hampered by a lack of healthcare facilities in low and middle-income countries, as well as a reluctance to accept epilepsy therapy.
Epilepsy Devices Market: Key Players
Boston Scientific Corporation
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Medpage Ltd. (Easylink UK)
Cerbomed GmbH (TVNS Technologies GmbH)
Liva Nova (Cyberonics)
Compumedics
Nihon Kohden
MC10
Empatica Inc
Medtronic Plc
Neuropace Inc
Epilepsy Devices Market: Regions
Epilepsy Devices market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. Epilepsy Devices market in North America held the largest market share in the year 2019. In the forecast period, the Epilepsy Devices market is expected to be dominated by North America. This is primarily due to the large number of businesses operating in the region, government regulations, and rising healthcare expenditure.
Epilepsy Devices Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – China, Japan, Australia, and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Epilepsy Devices report also contains analysis on:
Epilepsy Devices Segments:
By Product:
Conventional devices
Wearable devices
By End-User:
Home care settings
Clinics
Hospitals
Epilepsy Devices Market Dynamics
Epilepsy Devices Market Size
Supply & Demand
Current Market Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Epilepsy Devices Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2021 USD 626.1 million
Revenue forecast in 2030 USD 1115.3 million
Growth Rate CAGR of 6.62% from 2021 to 2030
Base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2030
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product, End-user, and Region
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
Key companies profiled Boston Scientific Corporation, Medpage Ltd. (Easylink UK), Cerbomed GmbH (TVNS Technologies GmbH), Liva Nova (Cyberonics), Compumedics, Nihon Kohden, MC10, Empatica Inc, Medtronic Plc, Neuropace Inc and Other Prominent Players.
Frequently Asked Questions
How big is the Epilepsy Devices market?
What is the Epilepsy Devices market growth?
Which segment accounted for the largest Epilepsy Devices market share?
Who are the key players in the Epilepsy Devices market?
What are the factors driving the Epilepsy Devices market?
Product Overview
Epilepsy is a chronic neurological condition that produces repeated unprovoked seizures, which are characterized by undetected episodes of uncontrollable movement involving either a portion or full body. The underlying cause of epilepsy, however, remains unclear. Epilepsy can be caused by strokes, trauma, brain tumors, infections, or birth defects in certain people. Because the condition is more common in children than in adults, general practitioners are more likely to see patients with epilepsy in their everyday practice. Depending on the symptoms of epilepsy, blood tests such as complete blood count, magnetic resonance imaging (MRI), computed tomography scanning (CT), and electroencephalograms (EEG) are used to diagnose the condition. The therapeutic gadgets provide novel treatment alternatives for epilepsy.
Market Highlights
Epilepsy Devices market is expected to project a notable CAGR of 6.62% in 2030
The increasing incidence of epilepsy among the geriatric population, rising occurrences of brain injuries due to road accidents, a huge patient pool suffering from neurological diseases, and expanding research funding in epilepsy are all contributing to the global market's growth.
Epilepsy Devices Market: Segments
Conventional devices segment to grow with the highest CAGR during 2020-30
Epilepsy Devices market is segmented by Product into Conventional devices and Wearable devices. Among these Conventional devices is expected to dominate the market during the forecast period. The extensive use of traditional EEG equipment in hospitals and clinics, the rising need for epilepsy monitoring in clinical trials, and the availability of payment for EEG treatments in developed nations all contribute to the segment's rise.
Hospitals & Clinics segment to grow with the highest CAGR during 2020-30
Epilepsy Devices market is segmented by End-User into Hospitals & Clinics, Forensic and Pharmaceutical manufacturing. Among these, the Hospitals & Clinics category had the highest revenue share in 2020. EEG monitoring and emergency medical services are most commonly used in hospitals and clinics. The market is expected to provide profitable opportunities, particularly in developing nations.
Market Dynamics
Drivers
Need for continuous monitoring to rise market growth
Continuous monitoring is required in severely ill epileptic patients to detect non-convulsive episodes (NCS). The cerebral cortical function is assessed by continuous monitoring. NCS is a condition that can affect children with encephalopathy. Adults' NCS outcomes change with time, possibly worsening their health. As a result, the demand for EEG systems rises as the requirement for continuous monitoring grows.
Increasing awareness
The global epilepsy treatment devices market is anticipated to develop due to increased awareness and technical improvements in epilepsy treatment options.
Restraint
Lack of healthcare facilities
The global epilepsy treatment devices market is projected to be hampered by a lack of healthcare facilities in low and middle-income countries, as well as a reluctance to accept epilepsy therapy.
Epilepsy Devices Market: Key Players
Boston Scientific Corporation
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Medpage Ltd. (Easylink UK)
Cerbomed GmbH (TVNS Technologies GmbH)
Liva Nova (Cyberonics)
Compumedics
Nihon Kohden
MC10
Empatica Inc
Medtronic Plc
Neuropace Inc
Epilepsy Devices Market: Regions
Epilepsy Devices market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. Epilepsy Devices market in North America held the largest market share in the year 2019. In the forecast period, the Epilepsy Devices market is expected to be dominated by North America. This is primarily due to the large number of businesses operating in the region, government regulations, and rising healthcare expenditure.
Epilepsy Devices Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – China, Japan, Australia, and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Epilepsy Devices report also contains analysis on:
Epilepsy Devices Segments:
By Product:
Conventional devices
Wearable devices
By End-User:
Home care settings
Clinics
Hospitals
Epilepsy Devices Market Dynamics
Epilepsy Devices Market Size
Supply & Demand
Current Market Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Epilepsy Devices Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2021 USD 626.1 million
Revenue forecast in 2030 USD 1115.3 million
Growth Rate CAGR of 6.62% from 2021 to 2030
Base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2030
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product, End-user, and Region
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
Key companies profiled Boston Scientific Corporation, Medpage Ltd. (Easylink UK), Cerbomed GmbH (TVNS Technologies GmbH), Liva Nova (Cyberonics), Compumedics, Nihon Kohden, MC10, Empatica Inc, Medtronic Plc, Neuropace Inc and Other Prominent Players.
Frequently Asked Questions
How big is the Epilepsy Devices market?
What is the Epilepsy Devices market growth?
Which segment accounted for the largest Epilepsy Devices market share?
Who are the key players in the Epilepsy Devices market?
What are the factors driving the Epilepsy Devices market?
1. EXECUTIVE SUMMARY
2. EPILEPSY DEVICES MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. EPILEPSY DEVICES MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. EPILEPSY DEVICES MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. EPILEPSY DEVICES MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Latin America: (Brazil, Mexico, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Conventional devices, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Wearable devices, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End-user: Market Share (2020-2030F)
12.3.1. Home care settings, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Clinics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Boston Scientific Corporation
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Medpage Ltd. (Easylink UK)
13.3. Cerbomed GmbH (TVNS Technologies GmbH)
13.4. Liva Nova (Cyberonics)
13.5. Compumedics
13.6. Nihon Kohden
13.7. MC10
13.8. Empatica Inc
13.9. Medtronic Plc
13.10. Neuropace Inc
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. EPILEPSY DEVICES MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. EPILEPSY DEVICES MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. EPILEPSY DEVICES MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. EPILEPSY DEVICES MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Latin America: (Brazil, Mexico, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Conventional devices, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Wearable devices, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End-user: Market Share (2020-2030F)
12.3.1. Home care settings, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Clinics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Boston Scientific Corporation
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Medpage Ltd. (Easylink UK)
13.3. Cerbomed GmbH (TVNS Technologies GmbH)
13.4. Liva Nova (Cyberonics)
13.5. Compumedics
13.6. Nihon Kohden
13.7. MC10
13.8. Empatica Inc
13.9. Medtronic Plc
13.10. Neuropace Inc
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
